Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laird Forrest

Showing results (81-90 of 102) with videos related to

Pageof 11
Sort By:
The Prostate|January 27, 2015
Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude miceRuibao Chen, Yunqi Zhao, Yan Huang, et al.
American Journal of Veterinary Research|November 27, 2012
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasRachel O Venable, Deanna R Worley, Daniel L Gustafson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2021
Cancer immunotherapy from biology to nanomedicineSalma B Abdelbaky, Mayar Tarek Ibrahim, Hebatallah Samy, et al.
The Laryngoscope|December 23, 2015
Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cellsMichael W Sim, Patrick T Grogan, Chitra Subramanian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2020
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trialsAric Huang, Melissa M Pressnall, Ruolin Lu, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisJoshua O Sestak, Bradley P Sullivan, Sharadvi Thati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 8, 2019
Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulatorRuolin Lu, Chad Groer, Peter A Kleindl, et al.
Journal of Pharmaceutical Sciences|July 10, 2025
Synthesis and characterization of modified nanodiamonds for use as a potential vaccine adjuvant delivery platform for a candidate ricin toxin vaccineMark Francis Seán Craven, Allison Jo Brachtenbach Mitchell, Kenneth Ryan Moulder, et al.
Therapeutic Delivery|November 27, 2015
Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrastQiuhong Yang, Maogang Gong, Shuang Cai, et al.
Molecular Pharmaceutics|November 1, 2024
Glatiramer Acetate Complexes CpG Oligodeoxynucleotides into Nanoparticles and Boosts Their TLR9-Driven ImmunityHuan Gong, J Daniel Griffin, Chad E Groer, et al.
Pageof 11

Showing results (81-90 of 102) with videos related to

Sort By:
Pageof 11
The Prostate|January 27, 2015
Nanomicellar TGX221 blocks xenograft tumor growth of prostate cancer in nude miceRuibao Chen, Yunqi Zhao, Yan Huang, et al.
American Journal of Veterinary Research|November 27, 2012
Effects of intratumoral administration of a hyaluronan-cisplatin nanoconjugate to five dogs with soft tissue sarcomasRachel O Venable, Deanna R Worley, Daniel L Gustafson, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 25, 2021
Cancer immunotherapy from biology to nanomedicineSalma B Abdelbaky, Mayar Tarek Ibrahim, Hebatallah Samy, et al.
The Laryngoscope|December 23, 2015
Effects of peritumoral nanoconjugated cisplatin on laryngeal cancer stem cellsMichael W Sim, Patrick T Grogan, Chitra Subramanian, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 17, 2020
Human intratumoral therapy: Linking drug properties and tumor transport of drugs in clinical trialsAric Huang, Melissa M Pressnall, Ruolin Lu, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitisJoshua O Sestak, Bradley P Sullivan, Sharadvi Thati, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 8, 2019
Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulatorRuolin Lu, Chad Groer, Peter A Kleindl, et al.
Journal of Pharmaceutical Sciences|July 10, 2025
Synthesis and characterization of modified nanodiamonds for use as a potential vaccine adjuvant delivery platform for a candidate ricin toxin vaccineMark Francis Seán Craven, Allison Jo Brachtenbach Mitchell, Kenneth Ryan Moulder, et al.
Therapeutic Delivery|November 27, 2015
Combining hard and soft magnetism into a single core-shell nanoparticle to achieve both hyperthermia and image contrastQiuhong Yang, Maogang Gong, Shuang Cai, et al.
Molecular Pharmaceutics|November 1, 2024
Glatiramer Acetate Complexes CpG Oligodeoxynucleotides into Nanoparticles and Boosts Their TLR9-Driven ImmunityHuan Gong, J Daniel Griffin, Chad E Groer, et al.
Pageof 11